The activation of epidermal growth factor receptor (EGFR) and the various downstream targets, such as Ras, Raf, MEK and ERK, are deeply implicated in the pathogenesis of PaCa with malignant transformation and enhanced tumour aggressiveness. The gene discussed is MAP2K7; the disease is permanent neonatal diabetes mellitus-pancreatic and cerebellar agenesis syndrome.